Structure |
Chemical Name |
CAS |
MF |
![6-Bromo-4-hydroxy-pyrazolo[1,5-a]pyridine-3-carbonitrile](/CAS/20200331/GIF/2068065-16-5.gif) |
6-Bromo-4-hydroxy-pyrazolo[1,5-a]pyridine-3-carbonitrile |
2068065-16-5 |
C8H4BrN3O |
![2,4,8,10-Tetraoxa-3,9-dithiaspiro[5.5]undecane, 3,3,9,9-tetraoxide](/CAS/20200331/GIF/201419-80-9.gif) |
2,4,8,10-Tetraoxa-3,9-dithiaspiro[5.5]undecane, 3,3,9,9-tetraoxide |
201419-80-9 |
C5H8O8S2 |
![(SP-4-1)-[1,3-Bis[2,6-bis(1-propylbutyl)phenyl]-4,5-dichloro-1,3-dihydro-2H-imidazol-2-ylidene]dichloro(3-chloropyridine-κN)-Palladium](/CAS/20210111/GIF/1814936-54-3.gif) |
(SP-4-1)-[1,3-Bis[2,6-bis(1-propylbutyl)phenyl]-4,5-dichloro-1,3-dihydro-2H-imidazol-2-ylidene]dichloro(3-chloropyridine-κN)-Palladium |
1814936-54-3 |
C48H70Cl5N3Pd |
![2-Bromo-7-chlorodibenzo[b,d]furan](/CAS/20200331/GIF/2355229-03-5.gif) |
2-Bromo-7-chlorodibenzo[b,d]furan |
2355229-03-5 |
C12H6BrClO |
 |
2’,3’-dideoxy-2’,3’-didehydroinosine |
|
|
 |
Fmoc-Ala-Ala-Asn-PABC-PNP |
1834516-06-1 |
C39H38N6O11 |
 |
2’-deoxyinosine |
|
|
 |
Anti-Ceftriaxong |
|
|
 |
(R)-2-((trifluoromethoxy)methyl)piperazine |
|
|
 |
benzyl (R)-2-(2,2-difluoroethyl)piperazine-1-carboxylate |
|
|
 |
tert-butyl (S)-2-((trifluoromethoxy)methyl)piperazine-1-carboxylate |
|
|
 |
tert-butyl (S)-2-(2,2,2-trifluoroethyl)piperazine-1-carboxylate |
1240582-25-5 |
C11H19F3N2O2 |
![N6-[(5-Bromothien-2-yl)methyl]adenosine](/CAS/20200611/GIF/1706525-09-8.gif) |
N6-[(5-Bromothien-2-yl)methyl]adenosine |
1706525-09-8 |
C15H16BrN5O4S |
 |
4-hydroxy-6H-coumarin |
213481-01-7 |
C15H15NO3 |
 |
1-Azetidinecarboxylic acid, 3-(4-iodo-1H-pyrazol-1-yl)-, 1,1-dimethylethyl ester |
951259-19-1 |
C11H16IN3O2 |
 |
Cefuroxime Impurity 1(Cefuroxime Mother Nucleus) |
|
|
 |
methyl 6-amino-7-fluoro-3H-benzimidazole-5-carboxylate |
918321-29-6 |
C9H8FN3O2 |
![7-bromo-2-chlorodibenzo[b,d]furan](/CAS/20210111/GIF/2351918-80-2.gif) |
7-bromo-2-chlorodibenzo[b,d]furan |
2351918-80-2 |
C12H6BrClO |
 |
tert-butyl 4-(4-bromothiazol-2-yl)-5,6-dihydropyridine-1(2H)-carboxylate |
1332301-87-7 |
C13H17BrN2O2S |
 |
2,5-Piperazinedione, 1-acetyl-3-(phenylmethylene)-, (3Z)- |
30166-30-4 |
C13H12N2O3 |
![(5R)-1-[(5S)-5-(4-Fluorophenyl)-5-hydroxy-1-oxopentyl]-5-phenyl-2-pyrrolidinone](/CAS/20180703/GIF/1027552-46-0.gif) |
(5R)-1-[(5S)-5-(4-Fluorophenyl)-5-hydroxy-1-oxopentyl]-5-phenyl-2-pyrrolidinone |
1027552-46-0 |
C21H22FNO3 |
 |
4F-MPH |
1354631-33-6 |
C14H18FNO2 |
 |
Oseltamivir-13CD3 |
1093851-61-6 |
C16H28N2O4 |
 |
3,5-Dibromo-1H-pyrazole |
67460-86-0 |
C3H2Br2N2 |
 |
2-cyanoethyl 4-(4-cyano-2-methoxyphenyl)-2,8-dimethyl-5-oxo-1,4,5,6-tetrahydro-1,6-naphthyridine-3-carboxylate |
1050477-43-4 |
C22H20N4O4 |
 |
2H-1-Benzopyran-2-one, 6-chloro-4-methyl- |
24145-78-6 |
C10H7ClO2 |
 |
-- |
93360-08-8 |
C30H27N2O6P |
 |
Tadanafil intermediate (chloroacetyl porphyrin) |
171596-59-1 |
C31H57BN4O6Si |
 |
4-acetyl-2-methylbenzoic acid |
55860-35-0 |
C10H10O3 |
 |
6-BROMO-4-HYDROXYCOUMARIN |
4139-61-1 |
C9H5BrO3 |
 |
ETHYL 5-ISOPROPYL-3-METHYLISOXAZOLE-4-CARBOXYLATE |
357326-79-5 |
C10H15NO3 |
 |
7-DEAZA-2'-DEOXYINOSINE |
97224-58-3 |
C11H13N3O4 |
![3-Iodo-1-(1-methyl-piperidin-4-ylmethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine](/CAS/20180529/GIF/1411763-96-6.gif) |
3-Iodo-1-(1-methyl-piperidin-4-ylmethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine |
1411763-96-6 |
C12H17IN6 |
 |
2-Bromodibenzofuran |
86-76-0 |
C12H7BrO |
 |
Ethyl 6,8-dichlorooctanoate |
1070-64-0 |
C10H18Cl2O2 |
 |
5-Methyl-3-phenylisoxazole-4-carbonyl chloride |
16883-16-2 |
C11H8ClNO2 |
 |
1-bromo-3-chloro-Dibenzofuran |
2043962-13-4 |
C12H6BrClO |
 |
2-(3,5-Dichlorophenyl)Pyrrolidine |
887344-13-0 |
C10H11Cl2N |
 |
4S-fluoropyrrolidine-2R-carboxylic acid methyl ester hydrochloride salt |
131176-03-9 |
C6H11ClFNO2 |
![3-Ethynyl-1-(1-methylethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine](/CAS/20200331/GIF/1189793-01-8.gif) |
3-Ethynyl-1-(1-methylethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine |
1189793-01-8 |
C10H11N5 |
 |
LOXO-292 |
2222755-14-6 |
C29H31N9O3 |
![1-Piperazinecarboxylic acid, 2-methyl-5-[[(3R)-3-methyl-4-morpholinyl]methyl]-, 1,1-dimethylethyl ester, (2R,5S)-](/CAS/20200331/GIF/1403902-78-2.gif) |
1-Piperazinecarboxylic acid, 2-methyl-5-[[(3R)-3-methyl-4-morpholinyl]methyl]-, 1,1-dimethylethyl ester, (2R,5S)- |
1403902-78-2 |
C16H31N3O3 |
 |
2-(2-Bromophenyl)pyrrolidine |
129540-24-5 |
C10H12BrN |
 |
7-Methyl-1-tetralone |
22009-37-6 |
C11H12O |
 |
PROSTAGLANDIN J2 |
60203-57-8 |
C20H30O4 |
 |
4-Acetoxyindole |
5585-96-6 |
C10H9NO2 |
 |
Prednisone Impurity 13 |
91160-89-3 |
C23H29BrO7 |
![methyl 2-(piperidin-4-yl)-1H-benzo[d]imidazole-5-carboxylate](/CAS/20200331/GIF/CB44869182.gif) |
methyl 2-(piperidin-4-yl)-1H-benzo[d]imidazole-5-carboxylate |
|
C14H17N3O2 |
 |
Thionicotinamide |
4621-66-3 |
C6H6N2S |
 |
1-(tert-butyl) 4-ethyl (3R,4R)-3-hydroxypiperidine-1,4-dicarboxylate |
206111-36-6 |
C13H23NO5 |
 |
7 8-DIHYDROXY-4-PHENYLCOUMARIN |
842-01-3 |
C15H10O4 |
 |
2-(4-METHOXY-BENZYL)-2H-PYRAZOL-3-YLAMINE |
3528-45-8 |
C11H13N3O |
 |
Ozagrel sodium |
130952-46-4 |
C13H13N2NaO2 |
 |
4-Bromo-1-chloroisoquinoline |
66728-98-1 |
C9H5BrClN |
![[2S-[2α(R*),3β]]-N-ForMyl-](/CAS/GIF/104872-28-8.gif) |
[2S-[2α(R*),3β]]-N-ForMyl- |
104872-28-8 |
C29H53NO5 |
 |
7-DesMethylagoMelatine |
152302-45-9 |
C14H15NO2 |
 |
5-(4-Bromophenyl)-4,6-dichloropyrimidine |
146533-41-7 |
C10H5BrCl2N2 |
 |
2-Propenoic acid, 3-(5-nitro-1-cyclohexen-1-yl)-, (2E)- |
899809-64-4 |
C9H11NO4 |
 |
Aegelin |
456-12-2 |
C18H19NO3 |
 |
1,2,4-cyclohexanetricarboxylic anhydride |
53611-01-1 |
C9H10O5 |
 |
(3R,4S)-tert-butyl 3,4-dihydroxypyrrolidine-1-carboxylate |
186393-22-6 |
C9H17NO4 |
 |
3,4-Diethyl 2-aMinothiophene-3,4-dicarboxylate |
104680-25-3 |
C10H13NO4S |
 |
1-(4-(3-Methoxy-4-nitrophenyl)piperazin-1-yl)ethanone |
1116229-11-8 |
C13H17N3O4 |
 |
Methyl (R)-4,4-difluoropyrrolidine-2-carboxylate hydrochloride |
1408057-39-5 |
C6H10ClF2NO2 |
 |
2-Methyl-N-(4-sulfaMoyl-phenyl)-acrylaMide |
56992-87-1 |
C10H12N2O3S |
 |
R 5011 (dopant) |
944537-61-5 |
C32H34O2 |
![N-Methyl-N-((3R,4R)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine dihydrochloride](/CAS/20150408/GIF/1260590-51-9.gif) |
N-Methyl-N-((3R,4R)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine dihydrochloride |
1260590-51-9 |
C13H20ClN5 |
 |
3-(Benzyloxy)-4-oxo-4h-pyran-2-carboxylic acid |
119736-16-2 |
C13H10O5 |
 |
SELEXIPAG interMediate |
475086-75-0 |
C23H27N3O |
 |
O-Methyl Dolutegravir |
1335210-35-9 |
C21H21F2N3O5 |
 |
2-PhenylpyriMidine-4-carboxylic acid |
16879-53-1 |
C11H8N2O2 |
![Ethyl 2-chloropyrazolo[1,5-a]pyriMidine-3-carboxylate](/CAS/20150408/GIF/1394003-65-6.gif) |
Ethyl 2-chloropyrazolo[1,5-a]pyriMidine-3-carboxylate |
1394003-65-6 |
C9H8ClN3O2 |
![tert-butyl [(2R,3S)-2-(2,5-difluorophenyl)-5-hydroxytetrahydro-2H-pyran-3-yl]carbaMate](/CAS/20150408/GIF/1172623-99-2.gif) |
tert-butyl [(2R,3S)-2-(2,5-difluorophenyl)-5-hydroxytetrahydro-2H-pyran-3-yl]carbaMate |
1172623-99-2 |
C16H21F2NO4 |
 |
N,N-Diphenyl-1H-imidazole-1-carboxamide |
2875-79-8 |
C16H13N3O |
 |
Pyrazolam |
39243-02-2 |
C16H12BrN5 |
 |
Coumarin |
10172-76-6 |
C27H21NO6 |
 |
4-(1-Fluoro-1-methyl-ethyl)-pyrimidine-5-carbaldehyde |
1427195-14-9 |
C8H9FN2O |
 |
4-(3-(allyloxymethyl)phenyl)-2-chloropyrimidine |
937273-29-5 |
C14H13ClN2O |
![tert-Butyl 2,8-diazaspiro[4.5]decane-2-carboxylate](/CAS/GIF/336191-17-4.gif) |
tert-Butyl 2,8-diazaspiro[4.5]decane-2-carboxylate |
336191-17-4 |
C13H24N2O2 |
 |
2-(tert-butoxycarbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid |
851784-82-2 |
C15H17Cl2NO4 |
 |
Pemetrexed intermediate |
|
|
 |
(2S,5S)-ethyl 5-methylpyrrolidine-2-carboxylate 2,2,2-
trifluoro acetate salt |
676560-85-3 |
C10H16F3NO4 |
![Pyridine, 4-[5-(4-pyridinyl)-1H-1,2,4-triazol-3-yl]-, 1-oxide](/CAS/20180702/GIF/36770-53-3.gif) |
Pyridine, 4-[5-(4-pyridinyl)-1H-1,2,4-triazol-3-yl]-, 1-oxide |
36770-53-3 |
C12H9N5O |
![3-bromodibenzo[b,d]thiophene](/CAS/20200331/GIF/97511-04-1.gif) |
3-bromodibenzo[b,d]thiophene |
97511-04-1 |
C12H7BrS |
 |
,100kg |
180048-73-1 |
C11H14O4S |
 |
1,2,4-butanetriol-3-(1,4,7,10-tetraazacyclododec-1-yl)4hydrochloride |
156077-56-4 |
C12H29ClN4O3 |
 |
trans-2,5-Bis(methoxymethyl)pyrrolidine |
144993-81-7 |
C8H17NO2 |
![(6R,7R)-7-AMINO-8-OXO-3-((2S)-TETRAHYDROFURAN-2-YL)-5-THIA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLIC ACID 4-NITROBENZYL ESTER HCL](/CAS/20180702/GIF/655233-39-9.gif) |
(6R,7R)-7-AMINO-8-OXO-3-((2S)-TETRAHYDROFURAN-2-YL)-5-THIA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLIC ACID 4-NITROBENZYL ESTER HCL |
655233-39-9 |
C18H20ClN3O6S |
 |
PPAP |
784118-64-5 |
C14H23N |
 |
Cefmetazole Impurity 4 |
68576-47-6 |
C15H17N7O4S4 |
 |
Otilonium Bromide intermediates |
51444-79-2 |
C22H27NO4 |
 |
2-Isopropoxy-5-methyl-4-(piperidin-4-yl)aniline dihydrochloride hydrate |
1802250-63-0 |
C15H27ClN2O2 |
 |
tert-butyl (3R,4S,5S)-4-((S)-2-amino-N,3-dimethylbutanamido)-3-methoxy-5-methylheptanoate |
177423-00-6 |
C19H38N2O4 |
![tert-butyl 6-bromo-3,3-dimethyl-2,3-dihydro-1H-pyrrolo[3,2-b]pyridine-1-carboxylate](/CAS/20180529/GIF/1403901-49-4.gif) |
tert-butyl 6-bromo-3,3-dimethyl-2,3-dihydro-1H-pyrrolo[3,2-b]pyridine-1-carboxylate |
1403901-49-4 |
C14H19BrN2O2 |
 |
MK-4618 Pyrimidinone Acid Sodium Salt |
1421271-01-3 |
C8H9N2NaO3 |
![4,6-Dibromo-pyrazolo[1,5-a]pyridine-3-carbonitrile](/CAS/20200119/GIF/2068065-63-2.gif) |
4,6-Dibromo-pyrazolo[1,5-a]pyridine-3-carbonitrile |
2068065-63-2 |
C8H3Br2N3 |
![4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-methylbenzoic acid](/CAS/20180529/GIF/864725-62-2.gif) |
4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-methylbenzoic acid |
864725-62-2 |
C18H12Cl2F3NO3 |
![4-Pyrimidinamine, 2-chloro-N-[2-[(1-methylethyl)sulfonyl]phenyl]-](/CAS/20180529/GIF/1197956-18-5.gif) |
4-Pyrimidinamine, 2-chloro-N-[2-[(1-methylethyl)sulfonyl]phenyl]- |
1197956-18-5 |
C13H14ClN3O2S |
 |
6-Fluoro-1-methyl-1H-indole-2-carboxylic acid |
893731-12-9 |
C10H8FNO2 |
![3-Bromo-11,11-dimethyl-11H-benzo[b]fluorene](/CAS/20180529/GIF/1674334-59-8.gif) |
3-Bromo-11,11-dimethyl-11H-benzo[b]fluorene |
1674334-59-8 |
C19H15Br |